Introducing Dialysis of Drugs. Our app includes extensive guidelines based on numerous literature sources and dialysis pharmacokinetic studies. Whether you need information on newly-approved medications, investigational agents, or drugs available in other countries, our guidelines have got you covered. We distinguish between conventional hemodialysis and high-permeability hemodialysis, taking into account factors such as duration of dialysis, flow rates, and dialysis membranes. Please note that this app does not provide information on drug dialyzability with continuous renal replacement therapy or plasmapheresis. For more specific details, visit our website at www.renalpharmacyconsultants.com, where you can find additional resources and explanatory materials. Stay informed and make confident decisions with the Dialyzability Guidelines app. Click here to download now.
Features of Dialysis of Drugs:
- Extensive drug dialyzability guidelines: The app provides comprehensive information on the dialyzability of various drugs, including newly-approved medications, investigational agents, and medications available in other countries. Users can find easy-to-read guidelines on drug removal during dialysis.
- Literature sources: The guidelines in the app are based on numerous literature sources, ensuring that the information provided is reliable and up-to-date.
- Differentiation between hemodialysis types: The app distinguishes between conventional hemodialysis and high-permeability (high-flux) hemodialysis, providing specific data for each type where available. This allows users to understand the differences in drug removal between these two dialysis methods.
- Reference website: Users are referred to the website www.renalpharmacyconsultants.com for additional background and explanatory material to aid in the interpretation of the tabular data. The website offers specific information on factors influencing drug dialyzability and special considerations like continuous renal replacement therapy (CRRT) and plasmapheresis.
- In vitro and in vivo evaluations: The website includes a table presenting sieving coefficient data from in vitro and in vivo evaluations. This information can be helpful in predicting dosing requirements during CRRT.
- Information on drugs of abuse: The website also provides a table regarding the removal of drugs of abuse, offering specific data for users who need information on these substances during dialysis.
Conclusion:
Its extensive guidelines, backed by reliable literature sources, provide information on the dialyzability of drugs. The differentiation between dialysis methods and the inclusion of data on drugs of abuse make it a comprehensive tool for healthcare providers. The reference website further enhances the app's usefulness, offering additional material for interpretation and prediction. Click here to download the app and access this valuable information.
